New pill tested for common skin condition
Disease control
Completed
This study tested a new oral medication called AX-158 for people with mild to moderate plaque psoriasis. For 28 days, 31 participants took either the drug or a placebo pill, followed by a safety check for another month. The main goal was to see if the drug was safe and well-toler…
Phase: PHASE1, PHASE2 • Sponsor: Artax Biopharma Inc • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC